Össur hf. - Other information disclosed according to the rules of the Exchange

Ossur Hf : Trading of Össur shares to be concentrated on Nasdaq Copenhagen from 6 December 2017

 Announcement no. 77/2017
 30 October 2017


Trading  of Össur shares to be concentrated on Nasdaq Copenhagen from 6 December
2017

Trading of Össur shares will soon be concentrated on Nasdaq Copenhagen following
Nasdaq  Iceland's decision  to accept  Össur's request  to cancel the trading of
Össur  shares on  Nasdaq Iceland.  By concentrating  the trading  on one market,
trading  liquidity of Össur shares will increase and the price formation will be
more effective for the benefit of all shareholders.

The  last trading  day of  Össur shares  on Nasdaq  Iceland will  be 30 November
2017. The  concentration of  trading on  Nasdaq Copenhagen  will occur  with the
automatic  conversion of shares tradable on  Nasdaq Iceland on 6 December 2017.
From that day all Össur shares will solely be tradeable on Nasdaq Copenhagen.

No  action is required  from shareholders and  the number of  shares will remain
unchanged.

The  cancellation  will  solely  affect  shareholders  that  have  Össur  shares
currently  tradable on Nasdaq Iceland. The  attached letter further explains the
process and the effects of the cancellation for those shareholders.

Nasdaq       Iceland's       announcement      can      be      found      here:
https://newsclient.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=807
532&lang=en

Jon Sigurdsson, President & CEO, comments:

"Össur was listed on Nasdaq Iceland in 1999, about 18 years ago. The listing was
instrumental  in  growing  Össur  from  a  small prosthetics company to a global
leader in non-invasive orthopaedics and we are grateful for the opportunities it
provided. By concentrating the trading of Össur shares on Nasdaq Copenhagen, the
trading  liquidity will increase and the  price formation will be more effective
for the benefit of all Össur shareholders."



Contact details

Jon Sigurdsson, President & CEO                                    +354 515 1300

Sveinn Solvason, CFO                                        +354 515 1300

David      Hreidarsson,      Investor     Relations
+354 515 1380                   dohreidarsson@ossur.com


Össur corporate announcements by e-mail
If you wish to receive Össur e-mail alerts, please register on our website:
www.ossur.com/investors.

About Össur
Össur (NASDAQ: OSSR) is a global leader in non-invasive orthopaedics that helps
people live a life without limitations.  Its business is focused on improving
people's mobility through the delivery of innovative technologies within the
fields of braces, supports, prosthetic limbs and compression therapy.  A
recognized "Technology Pioneer", Össur invests significantly in research and
product development; its award-winning designs ensuring a consistently strong
position in the market. Successful patient and clinical outcomes are further
empowered via Össur's educational programs and business solutions.
Headquartered in Iceland, Össur has major operations in the Americas, EMEA and
APAC, with additional distributors worldwide. www.ossur.com.


[]

Attachments:

Letter to shareholders.pdf